Potential interference of HTLV-1 HBZ protein with the DNA damage response pathway by Wurm, Torsten & Lemasson, Isabelle
MEETING ABSTRACT Open Access
Potential interference of HTLV-1 HBZ protein with
the DNA damage response pathway
Torsten Wurm*, Isabelle Lemasson
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
It takes decades after infection by HTLV-1 for an indivi-
dual to develop adult T-cell leukemia/lymphoma. This
disease is associated with increase genomic instability,
due to an alteration of the DNA damage response of the
infected cells. While this alteration has been attributed to
the viral protein Tax, we found that the viral protein
HBZ might also play a role in this process. In this study,
we found that expression of HBZ in Jurkat cells increases
the sensitivity of these cells to Etoposide treatment. Eto-
poside phosphate is an anticancer drug that induces
DNA damage. This drug acts by forming a ternary com-
plex with DNA and Topoisomerase II, leading to inhibi-
tion of the enzyme and creating double strand breaks. As
a result, errors are incorporated into the DNA and the
cells undergo apoptosis. We treated a stable cell line
expressing HBZ, or the backbone vector, with 12.5μM
Etoposide for 24 hrs. To determine the percentage of
viable cells as well as cells in early or late apoptosis, we
used a combination of Propidium iodide and Annexin V
staining. Interestingly, we found that the cells expressing
HBZ exhibit a 16% increase in total apoptotic cells and
a13 % increase in late apoptotic cells compared to the
cells expressing the backbone vector. This result suggests
that HBZ increases DNA damage following Etoposide
treatment. Current and future work investigates the effect
of HBZ on other activators of the DNA damage response
and tries to delineate the effect of HBZ on the regulation
of the DNA damage response pathway.
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